THALOMID

This brand name is authorized in Australia, New Zealand, United States

Active ingredients

The drug THALOMID contains one active pharmaceutical ingredient (API):

1 Thalidomide UNII 4Z8R6ORS6L - THALIDOMIDE

Thalidomide shows immunomodulatory, anti-inflammatory and potential anti-neoplastic activities. Thalidomide is also a non-barbiturate centrally active hypnotic sedative. It has no antibacterial effects. Read about Thalidomide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
THALOMID Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AX02	Thalidomide	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6469L, 9566L, 9667T, 9684Q
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14486, 14487, 14488, 14489
Country: US	FDA, National Drug Code	Identifier(s): 59572-205, 59572-210, 59572-215, 59572-220